Changes in cognitive function after thoracoscopic and catheter ablation for atrial fibrillation
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
Supported by the project National Institute for Research of Metabolic and Cardiovascular Diseases (CarDia), Programme EXCELES, ID Project No. LX22NPO5104. Funded by European Union - Next Generation EU, and by the Charles University Research program, Cooperatio - Cardiovascular Science
PubMed
36428282
DOI
10.1111/pace.14634
Knihovny.cz E-zdroje
- Klíčová slova
- atrial fibrillation, hybrid ablation, neurocognitive examination, pulmonary vein isolation, thoracoscopic ablation,
- MeSH
- fibrilace síní * chirurgie MeSH
- katetrizační ablace * metody MeSH
- kognice MeSH
- kognitivní dysfunkce * etiologie MeSH
- lidé MeSH
- recidiva MeSH
- venae pulmonales * chirurgie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Comparative data regarding the effect of percutaneous and thoracoscopic ablation of atrial fibrillation (AF) on cognitive function are very limited. The aim of the study was to determine and compare the effect of both types of ablations on patient cognitive functions in the mid-term. METHODS: Patients with AF indicated for ablation procedure were included. Forty-six patients underwent thoracoscopic, off-pump ablation using the COBRA Fusion radiofrequency system, followed by a catheter ablation three months afterward (Hybrid group). A comparative cohort of 53 AF patients underwent pulmonary vein isolation only (PVI group). Neuropsychological examinations were done before and nine months after the surgical or catheter ablation procedure. Neuropsychological testing comprised 13 subtests of seven domains, and the results were expressed as post-operative cognitive dysfunction (POCD) nine months after the procedure. RESULTS: Patients in both groups were similar with respect to the baseline clinical characteristics; only non-paroxysmal AF was more common in the hybrid group (98% vs. 34%). Major POCD was present in eight (17.4%) of hybrid patients versus three (5.7%) of PVI patients (p = 0.11), combined (major/minor) worsened cognitive decline was present in 10 (21.7%) hybrid patients versus three (5.6%) PVI patients (p = 0.034). On the other hand, combined (major/minor) improvement was present in 15 (32.6%) hybrid patients versus nine (16.9%) patients in the PVI group (p = 0.099). CONCLUSION: Hybrid ablation, a combination of thoracoscopic and percutaneous ablation, is associated with a higher risk of cognitive decline compared to sole percutaneous ablation.
Zobrazit více v PubMed
Packer DL, Piccini JP, Monahan KH, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143:1377-1390.
Haywood GA, Varini R, Osmancik P, et al. European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and long-standing persistent atrial fibrillation. IJC Heart Vascul. 2020;26:100459.
Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316-321.
Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012;184:E329-E336.
Lin T, Wissner E, Tilz R, et al. Preserving cognitive function in patients with atrial fibrillation. JAFIB. 2014;7.
Rasmusen LS, Larsen K, Houx P, Skovgaard LT, Hanning CD, Moller JT. The assesment of postoperative cognitive function. Acta Anaesth Scand. 2001;45:275-289.
Medi C, Evered L, Silbert B, et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2012;63:531-539.
Schwarz N, Kuniss M, Nedelmann M, et al. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm. 2010;7:1761-1767.
Herm J, Fiebach JB, Koch L, et al. Neuropsychological effects of MRI-detected brain lesions after catheter ablation for atrial fibrillation. long-term results of the MACPAF study. Circ Arrhythm Electrophysiol. 2013;6:843-850.
Jin MN, Kim TH, Kang KW, et al. Atrial fibrillation catheter ablation improves 1-year follow-up cognitive function, especially in patients with impaired cognitive function. Circ Arrhythm Electrophysiol. 2019;12:e007197.
Petersen P, Kastrup J, Videbaek R, Boysen G. Cerebral blood flow before and after cardioversion of atrial fibrillation. J Cereb Blood Flow Metab. 1989;9:422-425.
Osmancik P, Herman D, Kacer P, et al. The efficacy and safety of hybrid ablations for atrial fibrillation. JACC Clin Electrophysiol. 2021;7:1519-1529.
Malikova H, Kremenova K, Budera P, et al. Silent strokes after thoracoscopic epicardial ablation and catheter ablation for atrial fibrillation: not all lesions are permanent on follow-up magnetic resonance imaging. Quant Imaging Med Surg. 2021;11:3219-3233.
Knipp SC, Weimar C, Schlamann M, et al. Early and long-term cognitive outcome after conventional cardiac valve surgery. Interactive Cardio Vasc Thoracic Surg. 2017;24:534-541.
Nishtala A, Piers RJ, Himali JJ, et al. Atrial fibrillation and cognitive decline in the Framingham Heart Study. Heart Rhythm. 2018;15:166-172.
The importance of interdisciplinary research
